期刊
ATHEROSCLEROSIS SUPPLEMENTS
卷 4, 期 4, 页码 33-40出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/S1567-5688(03)00032-1
关键词
asymmetric dimethylarginine; nitric oxide; dimethylarginine dimethylaminohydrolase; cardiovascular disease
An increasing number of reports in the literature indicate that endogenously produced inhibitors of nitric oxide synthase (NOS), particularly asymmetric dimethylarginine (ADMA) regulate nitric oxide generation in numerous disease states. Two dimethylarginine dimethylaminobydrolase (DDAH) enzymes metabolise ADMA. We and others have postulated that activity of DDAH is a key determinant of ADMA levels in vivo. This review summarises recent advances in the regulation and function of DDAH enzymes and its role in the regulation of nitric oxide generation. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据